Work

Figure S4 from Synergism between IL21 and anti-PD-1 combination therapy is underpinned by coordinated reprogramming of the immune cellular network in the tumor microenvironment

Year: 2023

Type: other

Abstract: Supplementary Figure 4. IL21-anti-HSA and PD-1 mAbs synergy at the proliferation is due to upregulation of IL21R by PD-1 mAbs treatment and IL21 directly promotes proliferation on IL21R+ CD8+ T cells.

DOI: 10.1158/2767-9764.23676281.v1

Authors: Shaoxian Wu, Hao Huang, Runzi Sun, David Shihong Gao, Fan Ye, Jianing Huang, Ella Li, Andrew Ni, Kevin GuoKai Lu, Kong Chen, Jingting Jiang, Penelope A. Morel, Ziyang Zhong, Binfeng Lu

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4384204577

Cites:

Cited by:

Related to: 10